Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| PCPG | rs11532394 | chr12:53505173 | G/A | 1.19E-10 | 174 | 25.08 | 27.08 | 3.05 | KM Plot |
| PCPG | rs11542455 | chr12:53505437 | A/G | 1.19E-10 | 174 | 25.08 | 27.08 | 3.05 | KM Plot |
| PCPG | rs11542460 | chr12:53505510 | A/C | 1.19E-10 | 174 | 25.08 | 27.08 | 3.05 | KM Plot |
| PCPG | rs115438935 | chr2:118669672 | C/T | 1.6E-5 | 178 | 25.17 | 30.93 | 11.65 | KM Plot |
| PCPG | rs11544976 | chr17:1423412 | G/A | 1.37E-5 | 176 | 24.7 | 25.87 | 13.02 | KM Plot |
| PCPG | rs115516759 | chr2:176162562 | A/T | 0.000115 | 178 | 25.28 | 28.95 | 6.62 | KM Plot |
| PCPG | rs11556986 | chr7:105177041 | A/T | 7.23E-5 | 172 | 20.2 | 29.43 | 2.28 | KM Plot |
| PCPG | rs115609508 | chr7:105163716 | C/A | 5.12E-5 | 178 | 20.2 | 29.43 | 2.28 | KM Plot |
| PCPG | rs115621074 | chr1:36924631 | T/C | 8.21E-5 | 175 | 25.53 | 25.97 | 10.3 | KM Plot |
| PCPG | rs115648316 | chr7:154675660 | T/G | 9.19E-5 | 173 | 28.3 | 21.9 | 7.97 | KM Plot |
| PCPG | rs11575224 | chr12:56752154 | C/T | 9.85E-8 | 177 | 25.35 | 27.33 | 9.98 | KM Plot |
| PCPG | rs11575229 | chr12:56750737 | C/T | 9.85E-8 | 177 | 25.35 | 27.33 | 9.98 | KM Plot |
| PCPG | rs11575231 | chr12:56744445 | T/C | 9.85E-8 | 177 | 25.35 | 27.33 | 9.98 | KM Plot |
| PCPG | rs11575232 | chr12:56744422 | G/A | 9.85E-8 | 177 | 25.35 | 27.33 | 9.98 | KM Plot |
| PCPG | rs11575240 | chr12:56739857 | GCC/G | 9.68E-8 | 178 | 25.17 | 29.13 | 0.8 | KM Plot |